Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 70 Records) |
| Query Trace: Neoplasms and EZH2[original query] |
|---|
| Enhancer of zeste 2 polycomb repressive complex 2 subunit polymorphisms in melanoma skin cancer risk. Experimental dermatology 2020 Aug . Belpinati Francesca, Malerba Giovanni, Dal Toè Melissa, Ceccuzzi Laura, Rodolfo Monica, Poli Albino, Turco Alberto, Vergani Elisabetta, Sangalli Antonella, Gomez-Lira Macare |
| Stochastic Epigenetic Mutations Are Associated with Risk of Breast Cancer, Lung Cancer, and Mature B-cell Neoplasms. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 8 29 (10): 2026-2037. Gagliardi Amedeo, Dugué Pierre-Antoine, Nøst Therese H, Southey Melissa C, Buchanan Daniel D, Schmidt Daniel F, Makalic Enes, Hodge Allison M, English Dallas R, Doo Nicole W, Hopper John L, Severi Gianluca, Baglietto Laura, Naccarati Alessio, Tarallo Sonia, Pace Luigia, Krogh Vittorio, Palli Domenico, Panico Salvatore, Sacerdote Carlotta, Tumino Rosario, Lund Eiliv, Giles Graham G, Pardini Barbara, Sandanger Torkjel M, Milne Roger L, Vineis Paolo, Polidoro Silvia, Fiorito Giovan |
| The landscape of RNA polymerase II-associated chromatin interactions in prostate cancer. The Journal of clinical investigation 2020 4 130 (8): 3987-4005. Ramanand Susmita G, Chen Yong, Yuan Jiapei, Daescu Kelly, Lambros Maryou Bk, Houlahan Kathleen E, Carreira Suzanne, Yuan Wei, Baek GuemHee, Sharp Adam, Paschalis Alec, Kanchwala Mohammed, Gao Yunpeng, Aslam Adam, Safdar Nida, Zhan Xiaowei, Raj Ganesh V, Xing Chao, Boutros Paul C, de Bono Johann, Zhang Michael Q, Mani Ram |
| An LCM-based genomic analysis of SPEM, Gastric Cancer and Pyloric Gland Adenoma in an Asian cohort. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 4 33 (10): 2075-2086. Srivastava Supriya, Huang Kie Kyon, Rebbani Khadija, Das Kakoli, Fazreen Zul, Yeoh Khay Guan, Tan Patrick, Teh Mi |
| Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis. BioMed research international 2020 2020 2380124. Fan Kui, Zhang Chuan-Long, Qi Yuan-Fu, Dai Xin, Birling Yoann, Tan Zhao-Feng, Cao Fa |
| Expression of the epigenetic H3K27me3 modifier genes KDM6A and EZH2 in patients with upper tract urothelial carcinoma. Oncology letters 2020 10 20 (6): 349. Wang Yue, Zhang Jin-Xia, Wang Shu-Fang, Zhang Yu, He Hui-Yi |
| Increased gene expression variability in BRCA1-associated and basal-like breast tumours. Breast cancer research and treatment 2021 Jul . Wiggins George A R, Black Michael A, Dunbier Anita, Morley-Bunker Arthur E, , Pearson John F, Walker Logan |
| A rare variant in EZH2 is associated with prostate cancer risk. International journal of cancer 2021 Apr . Raspin Kelsie, FitzGerald Liesel M, Marthick James R, Field Matt A, Malley Roslyn C, Banks Annette, Donovan Shaun, Thomson Russell J, Foley Georgea R, Stanford Janet L, Dickinson Joanne |
| Identification and Validation a Necroptosis?related Prognostic Signature and Associated Regulatory Axis in Stomach Adenocarcinoma. OncoTargets and therapy 2021 12 14 5373-5383. Wang Ning, Liu Dingshe |
| Mutational Analysis of EZH2 Gene in Patients with Colorectal Adenoma Reveals a Genetic Variant Associated with Risk of Malignant Transformation. Asian Pacific journal of cancer prevention : APJCP 2021 12 22 (12): 4085-4094. Mahasneh Amjad A, Alnegresh Faten S, Alfaqih Mahmoud |
| Failure to EGFR-TKI-based therapy and tumoural progression are promoted by MEOX2/GLI1-mediated epigenetic regulation of EGFR in the human lung cancer. European journal of cancer (Oxford, England : 1990) 2021 Nov . Peralta-Arrieta Irlanda, Trejo-Villegas Octavio A, Armas-López Leonel, Ceja-Rangel Hugo A, Ordóñez-Luna María Del Carmen, Pineda-Villegas Priscila, González-López Marco A, Ortiz-Quintero Blanca, Mendoza-Milla Criselda, Zatarain-Barrón Zyanya L, Arrieta Oscar, Zúñiga Joaquín, Ávila-Moreno Federi |
| Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma. Cancer science 2021 Nov . Rai Shinya, Inoue Hiroaki, Sakai Kazuko, Hanamoto Hitoshi, Matsuda Mitsuhiro, Maeda Yasuhiro, Haeno Takahiro, Watatani Yosaku, Kumode Takahiro, Serizawa Kentaro, Taniguchi Yasuhiro, Hirase Chikara, Espinoza J Luis, Morita Yasuyoshi, Tanaka Hirokazu, Ashida Takashi, Tatsumi Yoichi, Nishio Kazuto, Matsumura Ita |
| Identification of Potential Biomarkers for Liver Cancer Through Gene Mutation and Clinical Characteristics. Frontiers in oncology 2021 11 733478. Cui Yunlong, Li Hua, Zhan Hongjie, Han Tao, Dong Yixuan, Tian Caijuan, Guo Yixian, Yan Fang, Dai Dong, Liu Pengf |
| Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 1 27 (6): 1671-1680. Song Joo Y, Perry Anamarija M, Herrera Alex F, Chen Lu, Skrabek Pamela, Nasr Michel R, Ottesen Rebecca A, Nikowitz Janet, Bedell Victoria, Murata-Collins Joyce, Li Yuping, McCarthy Christine, Pillai Raju, Wang Jinhui, Wu Xiwei, Zain Jasmine, Popplewell Leslie, Kwak Larry W, Nademanee Auayporn P, Niland Joyce C, Scott David W, Gong Qiang, Chan Wing C, Weisenburger Dennis |
| Phase 1 study of tazemetostat in Japanese patients with relapsed or refractory B-cell lymphoma. Cancer science 2021 1 112 (3): 1123-1131. Munakata Wataru, Shirasugi Yukari, Tobinai Kensei, Onizuka Makoto, Makita Shinichi, Suzuki Rikio, Maruyama Dai, Kawai Hidetsugu, Izutsu Koji, Nakanishi Tadashi, Shiba Sari, Hojo Seichiro, Ando Kiyos |
| Plasma Concentrations and Cancer-Associated Mutations in Cell-Free Circulating DNA of Treatment-Naive Follicular Lymphoma for Improved Non-Invasive Diagnosis and Prognosis. Frontiers in oncology 2022 12 870487. Hatipo?lu Tevfik, Esmeray Sönmez Esra, Hu Xiaozhou, Yuan Hongling, Danyeli Ayça Er?en, ?eyhanl? Ahmet, Önal-Süzek Tu?ba, Zhang Weiwei, Akman Burcu, Olgun Aybüke, Özkal Sermin, Alacac?o?lu ?nci, Özcan Mehmet Ali, You Hua, Küçük C |
| Regulation and Therapeutic Targeting of MTHFD2 and EZH2 in KRAS-Mutated Human Pulmonary Adenocarcinoma. Metabolites 2022 7 12 (7): . Li Yuchan, Elakad Omar, Yao Sha, von Hammerstein-Equord Alexander, Hinterthaner Marc, Danner Bernhard C, Ferrai Carmelo, Ströbel Philipp, Küffer Stefan, Bohnenberger Hanib |
| Analysis of EZH2 Genetic Variants on Triple-Negative Breast Cancer Susceptibility and Pathology. International journal of medical sciences 2022 19 (6): 1023-1028. Liu Liang-Chih, Chien Yi-Chung, Wu Guo-Wei, Hua Chun-Hung, Tsai I-Chen, Hung Chih-Chiang, Wu Tsai-Kun, Pan Ying-Ru, Yang Shun-Fa, Yu Yung-Lu |
| Clinical characteristics and outcomes of EZH2-mutant myelodysplastic syndrome: A large single institution analysis of 1774 patients. Leukemia research 2022 12 124 106999. Ball Somedeb, Aguirre Luis E, Jain Akriti G, Ali Najla Al, Tinsley Sara M, Chan Onyee, Kuykendall Andrew T, Sweet Kendra, Lancet Jeffrey E, Sallman David A, Hussaini Mohammad Omar, Padron Eric, Komrokji Rami |
| Determination of ERG(+), EZH2, NKX3.1, and SPINK-1 subtypes to evaluate their association with clonal origin and disease progression in multifocal prostate cancer. Cancer reports (Hoboken, N.J.) 2022 10 e1728. Segura-Moreno Yenifer Yamile, Sanabria-Salas María Carolina, Mesa-López De Mesa Jorge Andrés, Varela-Ramirez Rodolfo, Acosta-Vega Natalia Lizeth, Serrano Martha Luc |
| Association of EZH2 Genotypes With Oral Cancer Risk. In vivo (Athens, Greece) 2022 10 36 (6): 2669-2677. Shih Liang-Chun, Tsai Chia-Wen, Lin Tzu-Chieh, Wang Yun-Chi, He Jie-Long, Hsu Che-Lun, Hsia Te-Chun, Tsai Fuu-Jen, Yang Jai-Sing, Hsu Yuan-Man, Bau DA-Tian, Chang Wen-Sh |
| Predicting the prognosis of hepatocellular carcinoma based on the interaction between pyroptosis, apoptosis, and necroptosis. Clinical and experimental medicine 2022 Oct . Qian Fang, Kong Wei, Wang Shuaiqun, Wei K |
| An integrative approach toward identification and analysis of therapeutic targets involved in HPV pathogenesis with a focus on carcinomas. Cancer biomarkers : section A of Disease markers 2022 10 36 (1): 31-52. Gupta Amit Kumar, Kumar Man |
| Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively. Annals of surgery 2022 Aug . Bencivenga Maria, Simbolo Michele, Ciaparrone Chiara, Vicentini Caterina, Torroni Lorena, Piredda Maria Liliana, Sacco Michele, Alloggio Mariella, Castelli Claudia, Tomezzoli Anna, Scarpa Aldo, De Manzoni Giovan |
| EZH2 Expression and Survival for ER+/tamoxifen Treated Breast Cancer Patients with rs2302427 C>G: A Novel Prognostic and Risk Predictive Biomarker. Archives of medical research 2023 7 102852. Nisha Gautam, Satbir Kaur, Surender Kashy |
| Exploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han Population. OncoTargets and therapy 2023 7 16 499-513. Min Gao, Yongwen Li, Hua Huang, Yaguang Fan, Ruifeng Shi, Lianchun Su, Chen Chen, Xuanguang Li, Guangsheng Zhu, Di Wu, Peijun Cao, Hongyu Liu, Jun Chen, Shirong Ka |
| Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia. Blood advances 2023 5 . Joseph G W McCarter, David Nemirovsky, Christopher A Famulare, Noushin Farnoud, Abhinita S Mohanty, Zoe S Stone-Molloy, Jordan Chervin, Brian J Ball, Zachary D Epstein-Peterson, Maria E Arcila, Aaron J Stonestrom, Andrew Dunbar, Sheng F Cai, Jacob L Glass, Mark B Geyer, Raajit K Rampal, Ellin Berman, Omar I Abdel-Wahab, Eytan M Stein, Martin S Tallman, Ross L Levine, Aaron D Goldberg, Elli Papaemmanuil, Yanming Zhang, Mikhail Roshal, Andriy Derkach, Wenbin Xi |
| Modeling, dissecting, and subtyping of E-Cadherin inactivation-associated diffuse-type gastric adenocarcinoma. bioRxiv : the preprint server for biology 2023 3 . Zou Gengyi, Huang Yuanjian, Zhang Shengzhe, Ko Kyung-Pil, Kim Bong Jun, Zhang Jie, Pizzi Melissa P, Fan Yibo, Jun Sohee, Niu Na, Wang Huamin, Song Shumei, Ajani Jaffer A, Park Jae- |
| Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 11 OF1-OF8. Nitin Jain, Lisa J Croner, John N Allan, Tanya Siddiqi, Alessandra Tedeschi, Xavier C Badoux, Karl Eckert, Leo W K Cheung, Anwesha Mukherjee, James P Dean, Edith Szafer-Glusman, John F Seymo |
| Meta-analysis of Genetic polymorphism of Enhancer of Zeste Homolog2 gene in cancer susceptibility. Journal of cancer research and therapeutics 2023 10 19 (5): 1079-1092. Nisha Gautam, Mandeep Kaur, Surender Kashy |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 30, 2023
- Content source: